Double filtration plasmapheresis for a case of Crimean-Congo hemorrhagic fever

Transfusion and Apheresis Science

Volumn 48, Issue 3, 2013, Pages 331-334

  Meço, Başak C ^a   Memikoǧlu, Osman ^a   Ilhan, Osman ^a   Ayyildiz, Erol ^a   Gunt, Ceren ^a   Ünal, Necmettin ^a   Oral, Mehmet ^a   Tulunay, Melek ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; RIBAVIRIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CRIMEAN CONGO HEMORRHAGIC FEVER; DOUBLE FILTRATION PLASMAPHERESIS; ECCHYMOSIS; ENTEROCOCCUS FAECALIS; EPISTAXIS; ESCHERICHIA COLI INFECTION; FEVER; FIBRINOGEN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMATOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENSIVE CARE; INTERNATIONAL NORMALIZED RATIO; MALE; MELENA; PLASMAPHERESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TICK BITE; VEIN PUNCTURE; VIRUS LOAD;

ADULT; ANIMALS; FIBRINOGEN; FILTRATION; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PLASMAPHERESIS; RIBAVIRIN; TICK BITES; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84878860116     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.04.011     Document Type: Article

References (14)

1. Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006, 6(4):203-214.
2. Soares-Weiser K., Thomas S., Thomson G., Garner P. Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis. BMC Infect Dis 2010, 10:207.
3. Vorou R., Pierroutsakos I.N., Maltezou H.C. Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis 2007, 20(5):495-500.
4. Koksal I., Yilmaz G., Aksoy F., Aydin H., Yavuz I., Iskender S., et al. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol 2010, 47:65-68.
5. Keshtkar-Jahromi M., Kuhn J.H., Christova I., Bradfut S.B., Jahrling P.B., Bavari S. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antivir Res 2011, 90:85-92.
6. Mardani M., Jahromi M.K., Naieni K.H., Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin Infect Dis 2003, 36:1613-1618.
7. Izadi S., Salehi M. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study. Jpn J Infect Dis 2009, 62(1):11-15.
8. Elaldi N., Bodur H., Ascioglu S., Celikbas A., Ozkurt Z., Vahaboglu H., et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect 2009, 58(3):238-244.
9. Cevik M.A., Elaldi N., Akinci E., Ongürü P., Erbay A., Buzgan T., et al. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever. J Infect 2008, 57(4):350-351.
10. Cevik M.A., Erbay A., Bodur H., Eren S.S., Akinci E., Sener K., et al. Viral load as a predictor of outcome in Crimean-Congo haemorrhagic fever. Clin Infect Dis 2007, 45:96-100.
11. Duh D., Saksida A., Petrovec M., Ahmeti A., Dedushaj I., Panning M., et al. Viral load as predictor of Crimean-Congo haemorrhagic fever outcome. Emerg Infect Dis 2007, 13:1769-1772.
12. Namba T., Shiba R., Yamamoto T., et al. Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy. Clin Exp Nephrol 2010, 14:372-376.
13. Fujiwara K., Kaneko S., Kakumu S., Sata M., Hige S., Tomita E., et al. Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load. Hepatol Res 2007, 37:701-710.
14. Ishikawa T., Higuchi K., Kubota T., Seki K., Honma T., Yoshida T., et al. Complete early virological response was highly achieved by double filtration plasmapheresis plus IFN-beta induction therapy for HCV-1b patients with relapse or no response after previous IFN therapy. Ther Apher Dial 2011, 15(4):400-405.